Balversa
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 200, Titusville, New Jersey, 0856...Website
www.balversa.comRevenue
<$5 MillionIndustry
About Balversa
Is Balversa your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Balversa had a recent Job posting/layoffs
Product Launch: Get notified when Balversa launches new products
Earning: See what the market has to say on Balversa recently announced quarterly report
Check if Balversa has recently received funding, and reach out quickly before it becomes old news!
Balversa, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Balversa is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Balversa
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Balversa has new funding data
Recommended Actions
Reach out to Masked Content who joined Balversa as Masked Content
Find 3 more new buyers
Compare Similar Companies to Balversa
Compare insights from companies similar to Balversa, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Balversa is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Balversa is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Balversa.
Balversa Tech Stack
A closer look at the technologies used by Balversa
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Balversa
BALVERSA is a prescription medication designed for the treatment of adults with bladder cancer, specifically urothelial cancer that has either spread or is inoperable. The drug targets patients with a specific abnormal gene, FGFR, who have previously undergone systemic therapy without success. It is not recommended for individuals who are eligible... Read More